| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/02/2002 | WO2001058957A3 Enhancing the circulating half-life of antibody-based fusion proteins |
| 05/02/2002 | WO2001056544A3 Shell-and-core dosage form approaching zero-order drug release |
| 05/02/2002 | WO2001054686A3 L-arginine in combination with other compounds for treating cardiovascular diseases |
| 05/02/2002 | WO2001047512A3 Method for relieving pain associated with an internal disease site |
| 05/02/2002 | WO2001045744A3 Novel compounds of unsaturated fatty acids |
| 05/02/2002 | WO2001045667A3 Water-soluble powders for oral solution and use thereof |
| 05/02/2002 | WO2001032181A3 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum |
| 05/02/2002 | WO2001028525A3 Method of producing sub-micron particles of biologically active agents |
| 05/02/2002 | WO2001008671A3 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses |
| 05/02/2002 | US20020052594 Method and kit for imaging and treating organs and tissues |
| 05/02/2002 | US20020052481 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4 -IgG2 immunoconjugates, and uses thereof |
| 05/02/2002 | US20020052471 Human procalcitonin and the preparation and use thereof |
| 05/02/2002 | US20020052443 Non-antigenic branched polymer conjugates |
| 05/02/2002 | US20020052430 An activated, water soluble polymer comprising a polymer backbone having at least one terminus bonded to a branching atom through a hydrolytically stable linkage, and branching atom being covalently bonded to atleast two reactive groups |
| 05/02/2002 | US20020052422 Oral drug delivery compositions and methods |
| 05/02/2002 | US20020052421 Using mixture of water-insoluble carotenoid crystal and medium chain fatty acid triglyceride (MCT) as a core substance |
| 05/02/2002 | US20020052416 Use of prostaglandin EP-3 receptor antagonists as cosmetic agents for attenuating, reducing or stopping the loss of head hair and other hairs |
| 05/02/2002 | US20020052415 Treating chronic uremic patients undergoing periodical dialysis |
| 05/02/2002 | US20020052404 Compositions and methods for treating or preventing diseases of body passageways |
| 05/02/2002 | US20020052367 Pharmaceutical compositions containing carvedilol and hydrochlorothiazide |
| 05/02/2002 | US20020052320 Sustained peptide-release formulation |
| 05/02/2002 | US20020052319 Topical anesthetic/opioid formulations and uses thereof |
| 05/02/2002 | US20020052310 Bioactive agent in association with a charged lipid wherein the charged lipid has an overall net charge which is opposite to the overall net charge of the agent upon association and wherein release of the agent is sustained. |
| 05/02/2002 | US20020051990 Novel gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas |
| 05/02/2002 | US20020051824 Contacting an area of the skin showing symptoms of the hyperproliferative skin disorder such as psoriasis with silver or other noble metals in a nanocrystalline form |
| 05/02/2002 | US20020051820 Polymeric matrix swells upon imbibition of water thereby attaining a size large enough to promote retention in stomach during feeding mode, that releases drug into gastric fluid by dissolution and diffusion of the drug out of matrix |
| 05/02/2002 | US20020051819 Hexapeptide mixture with antimicrobial activity against Burkholderia cepacia and at least one carrier, effeactive for prevention of growth of Burkholderia cepacia for industrial, pharmeceutical, household and personal care use |
| 05/02/2002 | US20020051818 A core in the form of a tablet and having an enteric coating surrounding core, comprising an acid labile medicament, a binder or filler, a disintegrant and a lubricant, coating is formed of methacrylic acid copolymer and plasticizer |
| 05/02/2002 | US20020051816 Beta-lactam antibiotic-containing tablet and production thereof |
| 05/02/2002 | US20020051811 Method and composition for masking mineral taste |
| 05/02/2002 | US20020051808 Drug delivery system involving interaction between protein or polypeptide and hydrophobic biodegradable polymer |
| 05/02/2002 | US20020051803 Lotions containing vitamin D3 derivatives |
| 05/02/2002 | US20020051802 Rod-shaped mesoporous powder, humectant adsorbing powder, and cosmetic preparation using the same |
| 05/02/2002 | US20020051800 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain |
| 05/02/2002 | US20020051797 Of a hydrophilic polymer emulsion and a hydrophobic polymer emulsion; use to protect skin from irritants, chemical or pathogenic |
| 05/02/2002 | US20020051788 For covalently linking carbohydrates and proteins under neutral conditions, by attaching double bonds to a carrier protein, and attaching a conjugated diene to a carbohydrate hapten, then coupling; vaccines |
| 05/02/2002 | US20020051783 Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means |
| 05/02/2002 | US20020051776 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/02/2002 | US20020051775 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 05/02/2002 | US20020051774 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/02/2002 | US20020051773 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 05/02/2002 | US20020051772 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 05/02/2002 | US20020051763 Recombinant viral genome and nucleic acid sequence, carried by one or two plasmid supports, transcomplementing each other and allowing the host cell to produce defective infectious viruses |
| 05/02/2002 | US20020051749 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma |
| 05/02/2002 | EP1201762A1 Process for producing lycopen |
| 05/02/2002 | EP1201242A2 Use of mometasone furoate in an adjuvant therapy |
| 05/02/2002 | EP1201238A1 Sulfonamide derivatives and remedies for allodynia |
| 05/02/2002 | EP1201233A1 Transdermal dosage form |
| 05/02/2002 | EP1201232A1 Patches for external use |
| 05/02/2002 | EP1201231A2 Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticle, and therapeutic agent for treating zinc deficiency |
| 05/02/2002 | EP1201230A2 Solution-based transdermal drug delivery system comprising a vasodilator |
| 05/02/2002 | EP1201220A1 Cosmetic or pharmaceutical compositions containing thermostabilising microcapsules |
| 05/02/2002 | EP1201219A1 Use of thermostabilising microcapsules for improving the activity or the penetration of cosmetic or pharmaceutical active agents |
| 05/02/2002 | EP1201140A1 Calcium double salts, their synthesis and use as preservatives |
| 05/02/2002 | EP1201138A1 Carotenoid beads |
| 05/02/2002 | EP1200617A2 Methods for conditional transgene expression and trait removal in plants |
| 05/02/2002 | EP1200616A2 Enhanced delivery via serpin enzyme complex receptor ligands |
| 05/02/2002 | EP1200589A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 05/02/2002 | EP1200569A1 A method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 05/02/2002 | EP1200521A1 Dispersion comprising a non-ionic emulsifier |
| 05/02/2002 | EP1200519A1 Pre-formed, self-adhesive sheet devices suitable for topical application |
| 05/02/2002 | EP1200481A1 A biodegradable polycation composition for delivery of an anionic macromolecule |
| 05/02/2002 | EP1200461A2 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
| 05/02/2002 | EP1200455A1 Enzyme catalyzed therapeutic activation |
| 05/02/2002 | EP1200351A1 Electrolytic purification of calcium carbonate |
| 05/02/2002 | EP1200320A1 Valve with a two-component seal |
| 05/02/2002 | EP1200317A1 A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids |
| 05/02/2002 | EP1200137A1 Agent for occluding blood vessels |
| 05/02/2002 | EP1200131A2 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 05/02/2002 | EP1200129A1 Taste masking of oral quinolone liquid preparations using ion exchange resins |
| 05/02/2002 | EP1200128A1 Preserved pharmaceutical formulations |
| 05/02/2002 | EP1200127A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 05/02/2002 | EP1200125A1 Psca: prostate stem cell antigen and uses thereof |
| 05/02/2002 | EP1200123A1 Diagnosis and treatment of neuroectodermal tumors |
| 05/02/2002 | EP1200115A2 Multi-dose erythropoietin formulations |
| 05/02/2002 | EP1200109A1 Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
| 05/02/2002 | EP1200100A1 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration |
| 05/02/2002 | EP1200096A1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 05/02/2002 | EP1200091A1 Beta-carboline pharmaceutical compositions |
| 05/02/2002 | EP1200090A1 Beta-carboline pharmaceutical compositions |
| 05/02/2002 | EP1200082A1 Preparations for reducing oxygen consumption during physical efforts |
| 05/02/2002 | EP1200070A1 Ambroxol-containing lozenge |
| 05/02/2002 | EP1200069A1 A binder for pharmaceutical compositions |
| 05/02/2002 | EP1200067A1 Delivery system for biological material |
| 05/02/2002 | EP1200066A1 Aqueous nasal formulation |
| 05/02/2002 | EP1200065A1 Intravaginal clindamycin ovule composition |
| 05/02/2002 | EP1200064A1 Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip |
| 05/02/2002 | EP1200057A1 Colloidal composition for esthetic correction |
| 05/02/2002 | EP1200056A1 A process for stabilizing antioxidant compounds, and aqueous compositions |
| 05/02/2002 | EP1200042A2 Emulsifier-free finely dispersed systems of the oil-in-water type |
| 05/02/2002 | EP1200040A1 Two-component composition for cosmetic or pharmaceutical use |
| 05/02/2002 | EP1200039A2 Emulsifier-free finely dispersed water-in-oil-type systems |
| 05/02/2002 | EP1173192A4 Methods and compositions for targeted drug delivery |
| 05/02/2002 | EP1128835A4 Cyanocobalamin (vitamin b 12?) treatment in allergic disease |
| 05/02/2002 | EP0975216A4 A method for treating papillomavirus infections |
| 05/02/2002 | EP0941097B1 Use of mixtures of active substances for the production of hypocholesteremic agents |
| 05/02/2002 | EP0928192B1 Antimycotic gel with high active substance release |
| 05/02/2002 | EP0904031A4 Cationic polymer/lipid nucleic acid delivery vehicles |
| 05/02/2002 | EP0890359B1 Tablets containing beta-lactam antibiotic and process for producing the same |
| 05/02/2002 | EP0833628A4 Novel taxoids |